5 of the Most Hated Biotech Stocks on the Market: Are They Buys?
One of the best ways to measure how much a stock is hated is by looking at the percentage of the stock's float that's sold short. Short-sellers think so poorly of a stock that they're willing to put money on the line that its price will fall.
Five biotech stocks appear to have incurred a lot of hate based on their levels of short interest: Agios Pharmaceuticals (NASDAQ: AGIO), Insys Therapeutics (NASDAQ: INSY), Intercept Pharmaceuticals (NASDAQ: ICPT), Lexicon Pharmaceuticals (NASDAQ: LXRX), and Myriad Genetics (NASDAQ: MYGN). But are these hated stocks actually smart picks to buy right now?
Image source: Getty Images.
Source: Fool.com
Lexicon Pharmaceuticals Inc. Aktie
1,47 €
-2,33 %
Positive Tendenz für Lexicon Pharmaceuticals Inc. mit mehreren Buy- und keiner Sell-Einschätzung.
Mit einem Community-Kursziel von 9 € für Lexicon Pharmaceuticals Inc. wird ein starkes Wachstumspotenzial gegenüber dem aktuellen Kurs von 1.47 € gesehen.
